Westpac Banking Corp
AZN icon

Westpac Banking Corp’s AstraZeneca AZN Stock Holding History

Westpac Banking Corp’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.62M Buy
+22,206
New +$3.7M 0.22% 99

Other funds holding AZN

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $162B AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Westpac Banking Corp's AZN Position: Q3 2026 in Review

Westpac Banking Corp opened a new position in AstraZeneca (AZN) in Q3 2026: 22,206 shares worth $3.62M. The stake represents 0.22% of the portfolio and ranks #99 among its holdings.

1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Westpac Banking Corp held 22,206 shares of AstraZeneca worth $3.62M as of Q3 2026.
  • AstraZeneca was a new Westpac Banking Corp position in Q3 2026.
  • AstraZeneca made up 0.22% of Westpac Banking Corp's portfolio in Q3 2026, its #99 holding.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Westpac Banking Corp's 13F filing for Q3 2026, filed 10 Nov 2026.